Optimal timing of thoracic radiotherapy in limited stage small cell lung cancer (SCLC) with daily fractionation: A brief report.
Lung cancer
Small cell
Thoracic radiation
Journal
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
09
10
2018
revised:
06
11
2018
accepted:
07
11
2018
entrez:
4
3
2019
pubmed:
4
3
2019
medline:
29
1
2020
Statut:
ppublish
Résumé
Survival in limited stage small cell lung cancer (LS-SCLC) improves with faster initiation of hyper-fractionated thoracic radiotherapy (TRT) following chemotherapy, however, it is unknown if this association exists for more commonly employed daily fractionated regimens. Our results suggest that this association is present even with daily fractionation.
Identifiants
pubmed: 30825965
pii: S0167-8140(18)33586-2
doi: 10.1016/j.radonc.2018.11.005
pmc: PMC7427834
mid: NIHMS1614370
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
23-26Subventions
Organisme : NIGMS NIH HHS
ID : U54 GM104942
Pays : United States
Informations de copyright
Copyright © 2018 Elsevier B.V. All rights reserved.
Références
Lancet Oncol. 2017 Aug;18(8):1116-1125
pubmed: 28642008
Cancer Treat Rev. 2007 Aug;33(5):461-73
pubmed: 17513057
Ann Oncol. 2006 Apr;17(4):543-52
pubmed: 16344277
J Thorac Oncol. 2015 Dec;10(12):1770-5
pubmed: 26334750
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
J Clin Oncol. 2006 Mar 1;24(7):1057-63
pubmed: 16505424
Stat Med. 1998 Oct 15;17(19):2265-81
pubmed: 9802183
Ann Oncol. 2016 Oct;27(10):1818-28
pubmed: 27436850